Seroatlas · Human Serome Atlas

IGFBP3

Insulin-like growth factor-binding protein 3

Also known as: BP-53, IBP3, IBP3_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P17936
Gene
IGFBP3
Ensembl
ENSG00000146674
Chromosome
7
Canonical length
291 aa
Protein class
Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Vesicles
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

291 residues, UniProt reviewed canonical sequence.

>P17936|IGFBP3
     1  MQRARPTLWA AALTLLVLLR GPPVARAGAS SAGLGPVVRC EPCDARALAQ CAPPPAVCAE
    61  LVREPGCGCC LTCALSEGQP CGIYTERCGS GLRCQPSPDE ARPLQALLDG RGLCVNASAV
   121  SRLRAYLLPA PPAPGNASES EEDRSAGSVE SPSVSSTHRV SDPKFHPLHS KIIIIKKGHA
   181  KDSQRYKVDY ESQSTDTQNF SSESKRETEY GPCRREMEDT LNHLKFLNVL SPRGVHIPNC
   241  DKKGFYKKKQ CRPSKGRKRG FCWCVDKYGQ PLPGYTTKGK EDVHCYSMQS K

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IGFBP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.53
Highest tissue expression
1,749 nTPM

Expression across tissuesHPA

Tissue

  • placenta: 1,749 nTPM
  • liver: 668 nTPM
  • endometrium: 512 nTPM
  • urinary bladder: 346 nTPM
  • adipose tissue: 323 nTPM
  • blood vessel: 289 nTPM

Single-cell type

  • extravillous trophoblasts: 3,322 nCPM
  • endometrial secretory cells: 816 nCPM
  • hepatic stellate cells: 529 nCPM
  • migrating cytotrophoblasts: 493 nCPM
  • prostatic club cells: 458 nCPM
  • basal keratinocytes: 385 nCPM

Immune cell

  • plasmacytoid DC: 49 nTPM
  • memory CD4 T-cell: 9.7 nTPM
  • memory CD8 T-cell: 9.3 nTPM
  • gdT-cell: 8.8 nTPM
  • MAIT T-cell: 7.2 nTPM
  • naive CD8 T-cell: 7.2 nTPM

Brain region

  • hypothalamus: 24 nTPM
  • basal ganglia: 21 nTPM
  • pons: 21 nTPM
  • choroid plexus: 19 nTPM
  • medulla oblongata: 19 nTPM
  • cerebral cortex: 16 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IGFBP3.

Disease | ImmuneIEDB

Conditions an epitope on IGFBP3 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.39
gnomAD pLI
0.91
gnomAD missense Z
0.79
DepMap mean gene effect
-0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IGFBP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IGFBP3 as an antibody target. Whether an autoantibody or antibody against IGFBP3 could matter depends on whether native IGFBP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IGFBP3 is annotated as secreted, so native IGFBP3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label IGFBP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IGFBP3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...